<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02594540</url>
  </required_header>
  <id_info>
    <org_study_id>APA2016</org_study_id>
    <nct_id>NCT02594540</nct_id>
  </id_info>
  <brief_title>Effects of the Mechanical Peripheral Stimulation for Parkinson's Disease Rehabilitation</brief_title>
  <official_title>Effects of the Mechanical Peripheral Stimulation for Parkinson's Disease Rehabilitation - A Randomized Clinical Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Federal University of Health Science of Porto Alegre</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Gondola Medical Devices</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Politecnico di Milano</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Federal University of Health Science of Porto Alegre</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to evaluate safety and effectiveness of the peripheral
      mechanical stimulation of the feet on gait variables, clinical status, risk of falls, BDNF
      levels, immunological profile and brain functional connectivity changes in patients with
      Parkinson's disease.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Patients will be submitted to 8 sessions of peripheral mechanical stimulation of the feet or
      sham stimulation along 4 weeks.

      Evaluations will be performed before and after the first session, after the forth and the
      eighth session.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>December 2015</start_date>
  <completion_date type="Actual">September 2016</completion_date>
  <primary_completion_date type="Actual">September 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Kinetic and kinematic gait analysis</measure>
    <time_frame>4 weeks of treatment</time_frame>
    <description>Evaluated by means of the 3-D motion analysis system (BTS SMART DX 400).</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Risk of falls</measure>
    <time_frame>4 weeks of treatment</time_frame>
    <description>Evaluated by means of the Timed Up &amp; Go Test (TUG).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Motor impairment</measure>
    <time_frame>4 weeks of treatment</time_frame>
    <description>Evaluated by means of the Unified Parkinson Disease Rating Scale (UPDRS III).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Level of depression</measure>
    <time_frame>4 weeks of treatment</time_frame>
    <description>Evaluated by means of the Beck Depression Inventory (BDI).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Symptoms of Parkinson's disease progress</measure>
    <time_frame>4 weeks of treatment</time_frame>
    <description>Evaluated by means of the Hoehn and Yahr scale.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Serum levels of BDNF</measure>
    <time_frame>4 weeks of treatment</time_frame>
    <description>Analyzed in blood sampling.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Sensorio-motor connectivity</measure>
    <time_frame>4 weeks of treatment</time_frame>
    <description>Functional magnetic resonance imaging.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Lymphocyte Proliferation Assessment</measure>
    <time_frame>4 weeks of treatment</time_frame>
    <description>Analyzed in blood sampling.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Cytokine and Cortisol Assessment</measure>
    <time_frame>4 weeks of treatment</time_frame>
    <description>Analyzed in blood sampling.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">28</enrollment>
  <condition>Parkinson's Disease</condition>
  <arm_group>
    <arm_group_label>Feet Mechanical Stimulation</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>The feet mechanical stimulation will be given to all participants using GONDOLA equipment (Ecker Technologies Sagl, Switzerland). Intervention: Device: Foot Mechanical Stimulation (GONDOLA)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Sham Feet Mechanical Stimulation</arm_group_label>
    <arm_group_type>Sham Comparator</arm_group_type>
    <description>The sham stimulation will be given to all participants using GONDOLA equipment (Ecker Technologies Sagl, Switzerland). Intervention: Device: Foot Mechanical Stimulation (GONDOLA)</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Mechanical Peripheral Stimulation (GONDOLA)</intervention_name>
    <arm_group_label>Feet Mechanical Stimulation</arm_group_label>
    <arm_group_label>Sham Feet Mechanical Stimulation</arm_group_label>
    <other_name>GONDOLA equipment (Ecker Technologies Sagl, Switzerland)</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Diagnosis of idiopathic Parkinson's disease based on clinical criteria, dopamine
             transporter (DaT) scans and/or magnetic resonance imaging;

          -  Able to walk 25 feet unassisted or with minimal assistance;

          -  Presenting freezing of gait;

          -  Aged between 50-85 years;

          -  Minimum score of 20 in the Mini Mental State Examination (MMSE);

        Exclusion Criteria:

          -  Secondary musculoskeletal disorder involving the lower limb, as chondral injuries,
             ligament and ankle sprains which may impede the realization of the gait by pain or
             motion disability;

          -  Peripheral neuropathy;

          -  Not attending all the treatment;

          -  Absolute contraindications for fMRI (just for fMRI examination);

          -  Presence of deep brain stimulation;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>50 Years</minimum_age>
    <maximum_age>85 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Universidade Federal de Ciências da Saúde de Porto Alegre</name>
      <address>
        <city>Porto Alegre</city>
        <state>Rio Grande do Sul</state>
        <zip>90050-170</zip>
        <country>Brazil</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Brazil</country>
  </location_countries>
  <verification_date>January 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 30, 2015</study_first_submitted>
  <study_first_submitted_qc>October 30, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 3, 2015</study_first_posted>
  <last_update_submitted>January 11, 2017</last_update_submitted>
  <last_update_submitted_qc>January 11, 2017</last_update_submitted_qc>
  <last_update_posted type="Estimate">January 12, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Federal University of Health Science of Porto Alegre</investigator_affiliation>
    <investigator_full_name>Aline de Souza Pagnussat</investigator_full_name>
    <investigator_title>PhD</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Parkinson Disease</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

